Transcription of FULL PRESCRIBING INFORMATION
{{id}} {{{paragraph}}}
1 HIGHLIGHTS OF PRESCRIBING INFORMATIONT hese highlights do not include all the INFORMATION needed to use JYNARQUE safely and effectively. See full PRESCRIBING INFORMATION for (tolvaptan) tablets for oral useInitial Approval: 2009 WARNING: RISK OF SERIOUS LIVER INJURYSee full PRESCRIBING INFORMATION for complete boxed (tolvaptan) can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported ( )xMeasure transaminases and bilirubin before initiating treatment, at 2 weeks and 4 weeks after initiation, then continuing monthly for the first 18 months and every 3 months thereafter ( )xJYNARQUE is available only through a restricted distribution program called the JYNARQUE REMS Program ( )
JYNARQUE is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage The initial dosage for JYNARQUE is 60 mg orally per day as 45 mg taken on waking and 15 mg taken 8 hours later.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}